Patents
Genprex Secures Key Japanese and European Patents for REQORSA Gene Therapy Combined with Immunotherapies in Cancer Treatment
Genprex, Inc. has obtained favorable patent grants from the Japanese Patent Office and European Patent Office covering the use of its REQORSA gene therapy in combination with PD-L1 and PD-1 antibodies to treat cancer. These patents reinforce Genprex’s intellectual property rights in major markets and underpin its Accl…
Monday, February 23, 2026